JW Holdings Corporation (KRX:096760)
3,390.00
-5.00 (-0.15%)
Last updated: Sep 9, 2025, 1:23 PM KST
JW Holdings Revenue
JW Holdings had revenue of 228.38B KRW in the quarter ending June 30, 2025, with 6.36% growth. This brings the company's revenue in the last twelve months to 917.91B, up 0.24% year-over-year. In the year 2024, JW Holdings had annual revenue of 887.71B, down -4.35%.
Revenue (ttm)
917.91B
Revenue Growth
+0.24%
P/S Ratio
0.26
Revenue / Employee
7.23B
Employees
127
Market Cap
234.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
Dec 31, 2020 | 781.51B | 53.43B | 7.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
PharmaResearch | 449.81B |
Peptron | 5.18B |
LigaChem Biosciences | 148.28B |